Bolton Securities’s Medicus Pharma MDCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$16 Hold
2
– – ﹤0.01% 2235
2026
Q2
$45 Hold
2
– – ﹤0.01% 2207
2026
Q1
$46 Buy
+2
New +$104 ﹤0.01% 2010

Other funds holding MDCX

Bolton Securities's MDCX Position: Q3 2026 in Review

Bolton Securities held its Medicus Pharma (MDCX) position steady in Q3 2026 at 2 shares worth $16. The position accounts for ﹤0.01% of the portfolio, ranked #2235.

Bolton Securities first reported a position in MDCX in Q1 2026 and has held it in 3 quarters since. The position peaked at $46 in Q1 2026. 26 funds tracked by Wall St. Rank hold MDCX as of Q3 2026.

  • Bolton Securities held 2 shares of Medicus Pharma worth $16 as of Q3 2026.
  • Bolton Securities left its Medicus Pharma share count unchanged in Q3 2026.
  • Medicus Pharma made up ﹤0.01% of Bolton Securities's portfolio in Q3 2026, its #2235 holding.
  • Bolton Securities first reported a position in Medicus Pharma in Q1 2026 and has held it in 3 quarters since.
  • Bolton Securities's Medicus Pharma position peaked at $46 in Q1 2026.
  • 26 funds tracked by Wall St. Rank held Medicus Pharma as of Q3 2026.

Based on Bolton Securities's 13F filing for Q3 2026, filed 12 Nov 2026.